As a member of the management team, Bob raised more than $50 million in a major US / Canadian secondary offering and in excess of $200 million in other offerings.<br />Bob has extensive experience in negotiating and concluding licence arrangements and co-development agreements. He was one of Biomira&#39;s three members of the Joint Project Steering Committee with Merck KGaA which oversaw the strategic direction of the major Co-Development and Co-Promotion Agreement for Biomira&#39;s two lead product candidates. <br /><br />Bob is a founding member of the Centre for Biotechnology and Competitiveness for the Conference Board of Canada, a leading think tank. From 2004 to 2007 he was a board member of BioAlberta, the non-profit industry organisation for Alberta&#39;s biotech community